Historical shareholding details of
Public
holdings in Novelix Pharmaceuticals Ltd. (TRIMURTHI)
Quarterly changes of
Public
shareholding in Novelix Pharmaceuticals Ltd.
over the previous
quarters
|
Quarter
|
Name |
Total no. shares held |
Percent Holding |
Pledged
|
Locked
|
|
shares
|
%
|
shares
|
%
|
|
Jan 19, 2026
|
Total
|
8,667,267
|
49.22%
|
0
|
0.00%
|
4,228,985
|
74.39%
|
|
|
|
|
|
Dec 2025
|
Total
|
8,267,267
|
48.01%
|
0
|
0.00%
|
4,228,985
|
78.77%
|
|
|
|
|
|
Dec 24, 2025
|
Total
|
8,267,267
|
48.01%
|
0
|
0.00%
|
4,228,985
|
78.77%
|
|
|
|
|
|
Oct 23, 2025
|
Total
|
7,293,267
|
45.19%
|
0
|
0.00%
|
2,785,000
|
57.11%
|
|
|
|
|
|
Sep 2025
|
Total
|
6,757,267
|
46.66%
|
0
|
0.00%
|
2,785,000
|
63.47%
|
|
|
|
|
|
Aug 14, 2025
|
Total
|
6,757,267
|
46.65%
|
0
|
0.00%
|
2,785,000
|
63.13%
|
|
|
|
|
|
Jun 2025
|
Total
|
6,112,267
|
47.25%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2025
|
Total
|
3,327,267
|
33.44%
|
0
|
0.00%
|
526,525
|
48.57%
|
|
|
|
|
|
Dec 2024
|
Total
|
3,327,267
|
33.45%
|
0
|
0.00%
|
626,525
|
57.93%
|
|
|
|
|
|
Sep 2024
|
Total
|
3,327,267
|
33.44%
|
0
|
0.00%
|
300,000
|
27.91%
|
|
|
|
|
|
Jun 2024
|
Total
|
3,329,267
|
33.46%
|
0
|
0.00%
|
300,000
|
25.90%
|
|
|
|
|
|
Jun 11, 2024
|
Total
|
3,329,267
|
33.47%
|
0
|
0.00%
|
300,000
|
26.55%
|
|
|
|
|
|
Mar 2024
|
Total
|
2,679,267
|
33.08%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2023
|
Total
|
2,679,267
|
33.08%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2023
|
Total
|
2,679,267
|
33.08%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2023
|
Total
|
2,679,267
|
33.08%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2023
|
Total
|
2,679,267
|
33.08%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2022
|
Total
|
2,679,267
|
33.08%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2022
|
Total
|
2,679,267
|
33.08%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2022
|
Total
|
2,679,267
|
33.08%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2022
|
Total
|
2,679,267
|
33.08%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2021
|
Total
|
2,679,267
|
33.07%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2021
|
Total
|
2,679,267
|
33.08%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2021
|
Total
|
2,679,267
|
33.08%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2021
|
Total
|
2,679,267
|
33.09%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2020
|
Total
|
2,900,600
|
35.81%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2020
|
Total
|
2,900,600
|
35.81%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2020
|
Total
|
2,900,600
|
35.82%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2020
|
Total
|
2,900,600
|
35.81%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2019
|
Total
|
2,900,389
|
35.81%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2019
|
Total
|
2,900,600
|
35.80%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2019
|
Total
|
2,900,600
|
35.81%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2019
|
Total
|
2,900,600
|
35.81%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2018
|
Total
|
2,900,600
|
35.81%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2018
|
Total
|
2,900,600
|
35.81%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2018
|
Total
|
2,900,600
|
35.81%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2018
|
Total
|
2,900,600
|
35.81%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Dec 2017
|
Total
|
2,900,600
|
35.81%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Sep 2017
|
Total
|
2,900,600
|
35.82%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Jun 2017
|
Total
|
2,900,600
|
35.81%
|
0
|
0.00%
|
0
|
0.00%
|
|
|
|
|
|
Mar 2017
|
Total
|
2,900,600
|
35.81%
|
0
|
0.00%
|
0
|
0.00%
|
View all shareholdings details of Novelix Pharmaceuticals Ltd.